AIM: To examine whether plasma levels of coagulation factors II, V, IX, X, XI, and XII, plasminogen, and alpha-2 antiplasmin are associated with coronary heart disease (CHD) in a prospective case-cohort study. METHODS: This case-cohort sample consisted of 368 African-Americans or whites with incident CHD that occurred between 1990-92 and 1998, from the Atherosclerosis Risk in Communities (ARIC) study, and a cohort random sample of n=412. Hemostatic factors were measured in the case-cohort sample using plasma stored at -70 degrees C since 1990-92. RESULTS: After adjustments for age, sex and race, coagulation factors IX and XI, and alpha-2 antiplasmin were associated positively with risk of CHD: The hazard ratio [95% confidence interval] for the highest vs lowest quartiles was 1.52 [1.01-2.27] for factor IX; 2.26 [1.47-3.48] for factor XI; and 1.64 [1.05-2.57] for alpha-2 antiplasmin. However, as these hemostatic factors were correlated with classical risk factors, their association with CHD was attenuated and no longer statistically significant after multivariable adjustments. No association was observed between CHD and factor II, V, X, or XII, or plasminogen. CONCLUSIONS: Positive associations of factors IX and XI, and alpha-2 antiplasmin with incident CHD were not strong and accounted for by classical coronary risk factors.
RCT Entities:
AIM: To examine whether plasma levels of coagulation factors II, V, IX, X, XI, and XII, plasminogen, and alpha-2 antiplasmin are associated with coronary heart disease (CHD) in a prospective case-cohort study. METHODS: This case-cohort sample consisted of 368 African-Americans or whites with incident CHD that occurred between 1990-92 and 1998, from the Atherosclerosis Risk in Communities (ARIC) study, and a cohort random sample of n=412. Hemostatic factors were measured in the case-cohort sample using plasma stored at -70 degrees C since 1990-92. RESULTS: After adjustments for age, sex and race, coagulation factors IX and XI, and alpha-2 antiplasmin were associated positively with risk of CHD: The hazard ratio [95% confidence interval] for the highest vs lowest quartiles was 1.52 [1.01-2.27] for factor IX; 2.26 [1.47-3.48] for factor XI; and 1.64 [1.05-2.57] for alpha-2 antiplasmin. However, as these hemostatic factors were correlated with classical risk factors, their association with CHD was attenuated and no longer statistically significant after multivariable adjustments. No association was observed between CHD and factor II, V, X, or XII, or plasminogen. CONCLUSIONS: Positive associations of factors IX and XI, and alpha-2 antiplasmin with incident CHD were not strong and accounted for by classical coronary risk factors.
Authors: M C Minnema; R J Peters; R de Winter; Y P Lubbers; S Barzegar; K A Bauer; R D Rosenberg; C E Hack; H ten Cate Journal: Arterioscler Thromb Vasc Biol Date: 2000-11 Impact factor: 8.311
Authors: Jennifer I Berliner; Anne C Rybicki; Robert C Kaplan; E Scott Monrad; Ruth Freeman; Henny H Billett Journal: Thromb Res Date: 2002-07-15 Impact factor: 3.944
Authors: Christoph Merlo; Walter A Wuillemin; Maurice Redondo; Miha Furlan; Irmela Sulzer; Johanna Kremer-Hovinga; Bernd R Binder; Bernhard Lämmle Journal: Atherosclerosis Date: 2002-04 Impact factor: 5.162
Authors: Adam M Smiles; Nancy S Jenny; Zhonghua Tang; Alice Arnold; Mary Cushman; Russell P Tracy Journal: Thromb Haemost Date: 2002-04 Impact factor: 5.249
Authors: A D White; A R Folsom; L E Chambless; A R Sharret; K Yang; D Conwill; M Higgins; O D Williams; H A Tyroler Journal: J Clin Epidemiol Date: 1996-02 Impact factor: 6.437
Authors: G J Miller; H A Ireland; J A Cooper; K A Bauer; J H Morrissey; S E Humphries; M P Esnouf Journal: J Thromb Haemost Date: 2007-10-29 Impact factor: 5.824
Authors: Andrew P DeFilippis; Ilya Chernyavskiy; Alok R Amraotkar; Patrick J Trainor; Shalin Kothari; Imtiaz Ismail; Charles W Hargis; Frederick K Korley; Gregor Leibundgut; Sotirios Tsimikas; Shesh N Rai; Aruni Bhatnagar Journal: J Thromb Thrombolysis Date: 2016-07 Impact factor: 2.300
Authors: Duke Appiah; Oluwaseun E Fashanu; Susa R Heckbert; Mary Cushman; Bruce M Psaty; Aaron R Folsom Journal: Blood Coagul Fibrinolysis Date: 2017-07 Impact factor: 1.276
Authors: Alejandro Santos-Lozano; Pedro L Valenzuela; Francisco Llavero; Simone Lista; Pedro Carrera-Bastos; Harald Hampel; Helios Pareja-Galeano; Beatriz G Gálvez; Juan Antonio López; Jesús Vázquez; Enzo Emanuele; José L Zugaza; Alejandro Lucia Journal: Aging (Albany NY) Date: 2020-02-25 Impact factor: 5.682
Authors: Kristina Johansson; Jan-Håkan Jansson; Lars Johansson; Ingemar Bylesjö; Torbjörn K Nilsson; Mats Eliasson; Stefan Söderberg; Marcus Lind Journal: Cerebrovasc Dis Extra Date: 2017-04-21